Among the risk factors for bleeding, only age > 70 years and stroke/TIA showed a tendency toward statistical significance.
← all excerpts
An Exploratory Association Analysis of <i>ABCB</i><sub>1</sub> rs1045642 and <i>ABCB</i><sub>1</sub> rs4148738 with Non-Major Bleeding Risk in Atrial Fibrillation Patients Treated with Dabigatran or Apixaban.
1
—
—